559 related articles for article (PubMed ID: 437169)
41. Carbohydrate metabolism of Indian women taking steroid contraceptives.
Barsivala VM; Virkar K; Kulkarni RD
Fertil Steril; 1976 Jan; 27(1):87-91. PubMed ID: 1245247
[TBL] [Abstract][Full Text] [Related]
42. Growth hormone secretion in idiopathic precocious puberty: effect of medroxyprogesterone.
Kaplan S; Frasier SD; Costin G
J Pediatr; 1969 Jul; 75(1):133-8. PubMed ID: 5790396
[TBL] [Abstract][Full Text] [Related]
43. Serum medroxyprogesterone acetate (MPA) concentrations and ovarian function following intramuscular injection of depo-MPA.
Ortiz A; Hirol M; Stanczyk FZ; Goebelsmann U; Mishell DR
J Clin Endocrinol Metab; 1977 Jan; 44(1):32-8. PubMed ID: 833262
[TBL] [Abstract][Full Text] [Related]
44. Treatment of breast cancer with medroxyprogesterone acetate.
Muggia FM; Cassieth PA; Ochoa M; Flatow FA; Gellhorn A; Hyman GA
Ann Intern Med; 1968 Feb; 68(2):328-37. PubMed ID: 4306126
[TBL] [Abstract][Full Text] [Related]
45. Sequential regimen of the antiprogesterone RU486 and synthetic progestin for contraception.
Kekkonen R; Lähteenmäki P; Luukkainen T; Tuominen J
Fertil Steril; 1993 Oct; 60(4):610-5. PubMed ID: 8405512
[TBL] [Abstract][Full Text] [Related]
46. Unsuccessful treatment of acromegaly with medroxyprogesterone acetate.
Atkinson RL; Dimond RC; Howard WJ; Earll JM
Acta Endocrinol (Copenh); 1974 Sep; 77(1):19-25. PubMed ID: 4408390
[TBL] [Abstract][Full Text] [Related]
47. Mechanism of the postcoital contraceptive effect of LH-RH in the rat. I. Serum hormone levels during chronic LH-RH Administration.
Beattie CW; Corbin A; Cole G; Corry S; Jones RC; Koch K; Tracy J
Biol Reprod; 1977 Apr; 16(3):322-32. PubMed ID: 321040
[TBL] [Abstract][Full Text] [Related]
48. High-dose medroxyprogesterone acetate (MPA) treatment in advanced breast cancer. A review.
Ganzina F
Tumori; 1979 Oct; 65(5):563-85. PubMed ID: 390798
[TBL] [Abstract][Full Text] [Related]
49. Effect of hypothyroidism on hormone profiles in virgin, pregnant and lactating rats, and on lactation.
Hapon MB; Simoncini M; Via G; Jahn GA
Reproduction; 2003 Sep; 126(3):371-82. PubMed ID: 12968945
[TBL] [Abstract][Full Text] [Related]
50. Influence of two contraceptives on induction of mammary cancer in rats.
McCarthy JD
Am J Surg; 1965 Nov; 110(5):720-3. PubMed ID: 5862377
[TBL] [Abstract][Full Text] [Related]
51. A biological marker, strongly associated with early oral contraceptive use, for the selection of a high risk group for premenopausal breast cancer.
Olsson H; Borg A; Ewers SB; Fernö M; Möller T; Ranstam J
Med Oncol Tumor Pharmacother; 1986; 3(2):77-81. PubMed ID: 3747639
[TBL] [Abstract][Full Text] [Related]
52. Nidation in weanling rats treated with PMS and gonadal steroids.
Khan ZU; Meyer RK
Fertil Steril; 1969; 20(4):667-73. PubMed ID: 5795046
[TBL] [Abstract][Full Text] [Related]
53. Direct effects of medroxyprogesterone acetate (MPA) and megestrol acetate (MGA) on rat testicular steroidogenesis.
Barbieri RL; Ryan KJ
Acta Endocrinol (Copenh); 1980 Jul; 94(3):419-25. PubMed ID: 6968496
[TBL] [Abstract][Full Text] [Related]
54. Radioimmunoassay for medroxyprogesterone acetate (Provera) using the 11alpha-hydroxy succinyl conjugate.
Royer ME; Ko H; Campbell JA; Murray HC; Evans JS; Kaiser DG
Steroids; 1974 May; 23(5):713-30. PubMed ID: 4365969
[TBL] [Abstract][Full Text] [Related]
55. Stimulated plasma prolactin levels in women using medroxyprogesterone acetate or an intrauterine device for contraception.
Spellacy WN; Buhi WC; Birk SA
Fertil Steril; 1975 Oct; 26(10):970-81. PubMed ID: 810369
[TBL] [Abstract][Full Text] [Related]
56. Treatment of seizures with medroxyprogesterone acetate: preliminary report.
Mattson RH; Cramer JA; Caldwell BV; Siconolfi BC
Neurology; 1984 Sep; 34(9):1255-8. PubMed ID: 6540415
[TBL] [Abstract][Full Text] [Related]
57. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
Faundes A; Brache V; Tejada AS; Cochon L; Alvarez-Sanchez F
Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017
[TBL] [Abstract][Full Text] [Related]
58. Suppression of ovarian function with the transdermally given synthetic progestin ST 1435.
Laurikka-Routti M; Haukkamaa M; Lähteenmäki P
Fertil Steril; 1992 Oct; 58(4):680-4. PubMed ID: 1426309
[TBL] [Abstract][Full Text] [Related]
59. Factors affecting pituitary gonadotropin function in users of oral contraceptive steroids.
Scott JA; Brenner PF; Kletzky OA; Mishell DR
Am J Obstet Gynecol; 1978 Apr; 130(7):817-21. PubMed ID: 345817
[TBL] [Abstract][Full Text] [Related]
60. Exogenous progestins and breast cancer.
Stanford JL; Thomas DB
Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
